B Beermann

3.1k total citations
98 papers, 2.4k citations indexed

About

B Beermann is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, B Beermann has authored 98 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Pharmacology. Recurrent topics in B Beermann's work include Pharmacogenetics and Drug Metabolism (12 papers), Analytical Methods in Pharmaceuticals (12 papers) and Pharmaceutical studies and practices (11 papers). B Beermann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Analytical Methods in Pharmaceuticals (12 papers) and Pharmaceutical studies and practices (11 papers). B Beermann collaborates with scholars based in Sweden, United States and United Kingdom. B Beermann's co-authors include Margaretha Groschinsky‐Grind, Anders Rosén, Björn Lindström, Kjell Hellström, Bo Odlind, Christer Sylvén, Bror Jonzon, Ragnar Brandt, Gunnar Alván and Francisco Estévez and has published in prestigious journals such as The Lancet, Circulation and The American Journal of Medicine.

In The Last Decade

B Beermann

97 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Beermann Sweden 27 561 403 388 382 380 98 2.4k
F. Andreasen Denmark 32 568 1.0× 552 1.4× 381 1.0× 337 0.9× 338 0.9× 107 2.8k
Peter H. Vlasses United States 28 741 1.3× 486 1.2× 359 0.9× 227 0.6× 307 0.8× 176 2.9k
B. Whiting United Kingdom 28 303 0.5× 243 0.6× 492 1.3× 256 0.7× 460 1.2× 100 2.3k
Dennis E. Drayer United States 29 474 0.8× 554 1.4× 309 0.8× 170 0.4× 327 0.9× 64 2.5k
M. J. Kendall United Kingdom 29 497 0.9× 214 0.5× 401 1.0× 219 0.6× 407 1.1× 127 2.4k
J. H. G. Jonkman Netherlands 29 298 0.5× 382 0.9× 428 1.1× 246 0.6× 401 1.1× 115 2.4k
R. G. McAllister United States 30 1.0k 1.8× 358 0.9× 249 0.6× 212 0.6× 278 0.7× 68 2.5k
Thorir D. Bjornsson United States 28 538 1.0× 466 1.2× 295 0.8× 207 0.5× 244 0.6× 72 2.8k
PA Routledge United Kingdom 28 788 1.4× 308 0.8× 298 0.8× 141 0.4× 319 0.8× 107 2.4k
M. J. Kendall United Kingdom 29 654 1.2× 380 0.9× 466 1.2× 349 0.9× 115 0.3× 135 3.1k

Countries citing papers authored by B Beermann

Since Specialization
Citations

This map shows the geographic impact of B Beermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Beermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Beermann more than expected).

Fields of papers citing papers by B Beermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Beermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Beermann. The network helps show where B Beermann may publish in the future.

Co-authorship network of co-authors of B Beermann

This figure shows the co-authorship network connecting the top 25 collaborators of B Beermann. A scholar is included among the top collaborators of B Beermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Beermann. B Beermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahlin, Anna M. & B Beermann. (2007). Incorrect use of orlistat and sibutramine in clinical practice. European Journal of Clinical Pharmacology. 63(2). 205–209. 6 indexed citations
2.
Ekstrand, A. Jonas, et al.. (2005). Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure. European Journal of Clinical Pharmacology. 61(3). 209–214. 4 indexed citations
3.
Dahlin, Anna M., et al.. (2005). Press coverage and sales of Xenical in Sweden, 1998–2000. European Journal of Clinical Pharmacology. 61(4). 285–289. 4 indexed citations
4.
Yue, Qun‐Ying, B Beermann, B. Lindström, & O. Nyquist. (1997). No difference in blood thiamine diphosphate levels between Swedish Caucasian patients with congestive heart failure treated with furosemide and patients without heart failure. Journal of Internal Medicine. 242(6). 491–495. 29 indexed citations
5.
Lagerqvist, Bo, Christer Sylvén, B Beermann, G. Helmius, & Anders Waldenström. (1990). Intracoronary adenosine causes angina pectoris like pain - an inquiry into the nature of visceral pain. Cardiovascular Research. 24(8). 609–613. 33 indexed citations
6.
Sylvén, Christer, B Beermann, L. Kaijser, & Bror Jonzon. (1990). Nicotine Enhances Angina Pectoris-Like Chest Pain and Atrioventricular Blockade Provoked by Intravenous Bolus of Adenosine in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 16(6). 962–965. 6 indexed citations
7.
Jonzon, Bror, Christer Sylvén, B Beermann, & Ragnar Brandt. (1989). Adenosine receptor mediated stimulation of ventilation in man. European Journal of Clinical Investigation. 19(1). 65–71. 13 indexed citations
8.
Sylvén, Christer, B Beermann, Anders Waldenström, et al.. (1989). ANGINA PECTORIS, ADENOSINE, AND THEOPHYLLINE. The Lancet. 333(8650). 1328–1329. 2 indexed citations
9.
Alván, Gunnar, et al.. (1988). Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis. Clinical Pharmacology & Therapeutics. 44(4). 436–441. 21 indexed citations
10.
Beermann, B. (1988). Pharmacokinetics of lisinopril. The American Journal of Medicine. 85(3). 25–30. 37 indexed citations
11.
Sylvén, Christer, B Beermann, A. Edlund, et al.. (1988). Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine. European Heart Journal. 9(suppl N). 6–10. 24 indexed citations
12.
Beermann, B & Margaretha Grind. (1987). Clinical Pharmacokinetics of Some Newer Diuretics. Clinical Pharmacokinetics. 13(4). 254–266. 17 indexed citations
13.
Beermann, B, et al.. (1984). Lipoid pneumonia: an occupational hazard of fire eaters.. BMJ. 289(6460). 1728–1729. 23 indexed citations
14.
Beermann, B, Bo Odlind, & L Wibell. (1983). Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function.. PubMed. 19(3). 124–31. 1 indexed citations
15.
Odlind, Bo & B Beermann. (1980). Diuretic resistance: reduced bioavailability and effect of oral frusemide.. BMJ. 280(6231). 1577.1–1577. 22 indexed citations
16.
Beermann, B, Lars Fåhraeus, Margaretha Groschinsky‐Grind, & Björn Lindström. (1980). Placental Transfer of Hydrochlorothiazide. Gynecologic and Obstetric Investigation. 11(1). 45–48. 7 indexed citations
17.
Beermann, B & O Edhag. (1978). Depressive effects of carbamazepine on idioventricular rhythm in man.. BMJ. 2(6131). 171–172. 17 indexed citations
18.
Beermann, B. (1974). Pharmacokinetics of Digitalis Glycosides. Drugs. 7(6). 482–485. 4 indexed citations
19.
Beermann, B & Kjell Hellström. (1971). The Efficacy of Lymph Drainage in the Elimination of Orally Administered Digitoxin and Digoxin. Pharmacology. 6(1). 17–21. 6 indexed citations
20.
Beermann, B, et al.. (1971). Absorption of14C-methylscopolamine from the digestive tract. European Journal of Clinical Pharmacology. 4(1). 46–51. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026